Innovative MedTech, Inc.
IMTH
$0.688
$0.31684.95%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -6.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -6.13% | |||
| Cost of Revenue | -- | 21.23% | |||
| Gross Profit | -- | -26.96% | |||
| SG&A Expenses | 5.74% | -69.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.41% | -64.39% | |||
| Operating Income | -29.94% | 73.06% | |||
| Income Before Tax | -25.52% | 86.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.52% | 86.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.26% | 86.77% | |||
| EBIT | -29.94% | 73.06% | |||
| EBITDA | -30.28% | 73.25% | |||
| EPS Basic | -14.11% | 87.00% | |||
| Normalized Basic EPS | -12.56% | 72.32% | |||
| EPS Diluted | -14.11% | 87.00% | |||
| Normalized Diluted EPS | -12.56% | 72.32% | |||
| Average Basic Shares Outstanding | 11.44% | 1.91% | |||
| Average Diluted Shares Outstanding | 11.44% | 1.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
